[go: up one dir, main page]

Wonigeit et al., 2004 - Google Patents

IMMUNOGENICITY OF POLYMORPHIC RECEPTOR FAMILIES ENCODED BY THE NATURAL KILLER GENE COMPLEX OF THE RAT

Wonigeit et al., 2004

Document ID
18129106914866660685
Author
Wonigeit K
Lambracht-Washington D
Raber K
Hundrieser J
Publication year
Publication venue
Transplantation

External Links

Snippet

Methods: included typing for NKC gene polymorphisms by RFLP and PCR, FACS analysis of expressed receptor proteins as well as various immunization strategies and in vitro assays. Results:(1) LEW and LEW. NKC (BS) differed at the gene level in all tested gene …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Isaac et al. TRANSPLANTATION OF NEONATAL PORCINE ISLETS AND SERTOLI CELLS INTO NON-IMMUNOSUPPRESSED NON-HUMAN PRIMATES
Wang et al. XENO-TRANSPLANTATION OF NEONATAL PORCINE ISLETS AND SERTOLI CELLS INTO NON-IMMUNOSUPPRESSED STREPTOZOTOCIN INDUCED DIABETIC RATS
Koyamada et al. MACROPHAGE DEPLETION PREVENTS ANTI-GRAFT ANTIBODY PRODUCTION AND RESULTS IN LONG TERM SURVIVAL IN XENOTRANSPLANTATION
Brenner et al. Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboons
Yan et al. Control of intestinal allograft rejection by FTY720 and costimulation blockade
Tanemura et al. SYNERGISTIC EFFECTS ON THE INHIBITION OF HUMAN CD8+ CYTOTOXIC T LYMPHOCYTES-MEDIATED KILLING AGAINST XENOGRAFT CELLS BY CO-EXPRESSION OF MEMBRANE-BOUND HUMAN FASL AND DECOY FAS ANTIGEN
Zhou et al. Production of triple transgenic pigs expressing human Cd59, Mcp and Daf
Wonigeit et al. IMMUNOGENICITY OF POLYMORPHIC RECEPTOR FAMILIES ENCODED BY THE NATURAL KILLER GENE COMPLEX OF THE RAT
Zhang et al. BLOCKING NF-KAPPAB ACTIVATION IN RECIPIENT T CELLS PROLONGS SMALL BOWEL ALLOGRAFT SURVIVAL IN A MOUSE MODEL OF ORTHOTOPIC SB TRANSPLANTATION
Garkavenko et al. IDENTIFICATION OF PIG CIRCOVIRUS TYPE 2 IN NEW ZEALAND PIGS.
Tang et al. IMMUNOBIOLOGICAL CHARACTERISTICS OF THE SLA P1-SPECIFIC HUMAN T CELL LINES AND THE P1 EPITOPE ANALYSIS IN CONTEXT OF HLA CLASS II MOLECULES
Ishiyama et al. POTENTIAL OF THE UTILIZATION OF NK CELLS EXTRACTED FROM PERFUSATES OF DONOR GRAFT LIVERS OR HOST CIRRHOTIC LIVERS AS AN ADJUVANT ANTICANCER THERAPY AFTER LIVER TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA.
Ziolkowski et al. PORCINE ENDOGENOUS RETROVIRUS (PERV) IS A MAJOR XENOANTIGEN FOR PORCINE CELL XENOGRAFTS IN MICE
Garkavenko et al. XENOTRANSPLANTATION OF NEONATAL PIG LIVER CELLS
Hundrieser et al. GENETIC POLYMORPHISM OF THE NKR-P1 RECEPTOR FAMILY IN THE RAT
Komoda et al. ADULT PORCINE ISLET TRANSPLANTATION FROM N-ACETYLGLUCOSAMINYL-TRANSFERASE-III (GNT-III) TRANSGENIC PIGS IN CYNOMOLGUS MONKEYS
Mitsuta et al. TRANSPLANTED AUTOLOGOUS HEPATOCYTES ARE ELIMINATED BY LIVER NK CELLS EXPRESSING TRAIL WHICH LACK EXPRESSION OF INHIBITORY RECEPTORS RECOGNIZING SELF MHC CLASS I MOLECULES
Huy et al. Treatment of Acetaminophen-Induced Fulminant Liver Failure By Transplantation of Encapsulated Immortalized Xenogeneic Hepatocytes
Mai et al. ANTI-CD25 MAB, ANTI-IL2 MAB AND IL2 BLOCK TOLERANCE INDUCTION THROUGH ANTI-CD154 MAB AND RAPAMYCIN IN XENOGENEIC ISLET TRANSPLANTATION
Bedke et al. INHIBITION OF HUMAN ANTI-PIG T CELL RESPONSES BY MONOCLONAL ANTIBODIES TO PORCINE CD45 MOLECULES
Hazama et al. COMPLEMENT REGULATORY PROTEINS SHOULD BE EXPRESSED AS A TRANSMEMBRANE FORM IN TRANSGENIC PIGS WITH RESPECT TO PERV INFECTION
Kawamoto et al. PREVENTING HUMAN CD8+ CYTOTOXIC T LYMPHOCYTES (CTL)-MEDIATED CYTOTOXICITY AGAINST SWINE ENDOTHELIAL CELLS BY OVEREXPRESSION OF HUMAN DECOY FAS ANTIGEN
Guo et al. MONOCLONAL ANTIBODY AGAINST AN INDUCIBLE CO-STIMULATOR (ICOS) COMBINING WITH ADCTLA-4IG INDUCE POTENEIAL IMMUNE MOUSE MONOCLONAL ANTIBODY AGAINST AN INDUCIBLE CO-STIMULATOR (ICOS) COMBINING WITH ADCTLA-4IG INDUCE POTENEIAL IMMUNE TOLERANCE
Schaffellner et al. Islet Cells Microencapsulated in Natrium Cellulose Sulphate
Safley et al. EOSINOPHIL INFILTRATION AND ELEVATED IL-5 LEVELS CORRELATE WITH REJECTION OF ENCAPSULATED PORCINE ISLET XENOGRAFTS IN DIABETIC NOD MICE, BUT DEPLETION OF EOSINOPHILS WITH ANTI-IL-5 MAB DOES NOT PROLONG GRAFT SURVIVAL.